Business Segment
(Millions of yen)
| 2021/3 | 2022/3 | 2023/3 | 2024/3 | 2025/3 | |
|---|---|---|---|---|---|
| New ethical drugs, etc. (Japan) | 69,735 | 69,725 | 74,770 | 82,581 | 84,158 | 
| New ethical drugs (Overseas) | 996 | 1,033 | 308 | 386 | 8,860 | 
| Generic drugs | 32,172 | 34,775 | 38,190 | 36,564 | 37,068 | 
| Net sales | 102,904 | 105,534 | 113,270 | 119,532 | 130,087 | 
“Accounting Standards for Revenue Recognition” (ASBJ Statement No.29, Mar 31, 2020) etc. have been applied from the beginning of March 2022.
Main Products
Beova
                    - Therapeutic agent for overactive bladder
 - Beova Tablets 50mg
 
Lasvic
                    - New Quinolone synthetic antibacterial agent
 - Lasvic Tablets 75mg
 - Lasvic Intravenous Drip Infusion Kit 150mg
 
Lyfnua
                    - Cough treatment
 - Lyfnua tablets 45mg
 
Desalex
                    - Antiallergic Agent
 - Desalex Tablets 5mg
 
Flutiform
                    - Combination drug for asthma treatment
 - Flutiform 50 Aerosol - 56 inhalations / 120 inhalations
 - Flutiform 125 Aerosol - 56 inhalations / 120 inhalations
 
Pentasa
                    - Ulcerative Colitis / Crohn's Disease Remedy
 - PENTASA Tablets 250mg
 - PENTASA Tablets 500mg
 - PENTASA Granules 94%
 - Ulcerative Colitis Remedy
 - PENTASA Enema 1g
 - PENTASA Suppositories 1g
 
Kipres
                    - Leukotriene receptor antagonist
Anti-Bronchial asthma and allergic rhinitis drug - KIPRES Tablets 5mg
 - KIPRES Tablets 10mg
 - KIPRES OD Tablets 10mg
 - Leukotriene receptor antagonist
Anti-Bronchial asthma drug - KIPRES Fine Granules 4mg
 - KIPRES Chewable Tablets 5mg
 
Mucodyne
                    - Mucoregulating drug
 - MUCODYNE Tablets 250mg
 - MUCODYNE Tablets 500mg
 - MUCODYNE Syrup 5%
 - MUCODYNE DS 50%
 
Montelukast “KM”
                    - Treatment for Bronchial asthma, allergic rhinitis
 - MONTELUKAST Tablets 5mg “KM”
 - MONTELUKAST Tablets 10mg “KM”
 
Mometasone “KYORIN”
                    - Allergic Rhinitis Therapeutic Agent
 - MOMETASONE NASAL 50μg “KYORIN”56sprays
 - MOMETASONE NASAL 50μg “KYORIN”112sprays
 
(Billions of yen)
| 2021/3 | 2022/3 | 2023/3 | 2024/3 | 2025/3 | |
|---|---|---|---|---|---|
| Beova | 7.3 | 8.6 | 12.9 | 18.1 | 22.1 | 
| Lasvic | 0.9 | 1.8 | 2.5 | 4.9 | 7.8 | 
| Lyfnua | - | - | 0.2 | 0.8 | 0.9 | 
| Desalex | 5.7 | 7.1 | 8.5 | 8.9 | 9.6 | 
| Flutiform | 13.3 | 12.6 | 12.0 | 12.9 | 13.7 | 
| Pentasa | 12.8 | 14.0 | 12.8 | 12.3 | 12.2 | 
| Kipres | 8.3 | 8.4 | 6.6 | 7.0 | 3.5 | 
| Mucodyne | 3.3 | 3.5 | 3.5 | 4.2 | 3.6 | 
| Montelukast “KM” | 10.8 | 12.2 | 13.3 | 12.3 | 12.0 | 
| Mometasone “KYORIN” | 3.8 | 3.6 | 4.7 | 4.5 | 4.1 | 
